KVUE
$17.77
Kenvue Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Healt...
Recent News
Newell Brands: Can Cost Cuts Offset Soft Consumer Demand?
NWL launches a productivity plan using AI and automation to counter weak demand and drive cost savings.
How Investors May Respond To Kenvue (KVUE) Earnings Beat And Segment Strength Amid Beauty Reboot
In early March 2026, Kenvue reported Q4 and full-year 2025 results that showed sales growth across all segments and adjusted EPS above market expectations. Analysts highlighted that while Kenvue’s Self Care and Essential Health categories are performing well, its beauty portfolio may require a different approach centered on premiumization and product innovation. Next, we’ll examine how Kenvue’s earnings beat and segment strength, especially in Self Care, may influence its existing...
Unilever vs. Kimberly-Clark: Two Consumer Staples Giants, One Better Dividend
Unilever (NYSE:UL) reported full-year 2025 results on February 12, while Kimberly-Clark (NYSE:KMB) dropped Q4 2025 numbers on January 27. Both are consumer staples giants mid-portfolio reshuffle, and both pay growing dividends. But how do the two compare for income investors? Portfolio Surgery at Both Companies, Different Scalpels Unilever completed its Ice Cream demerger in December ... Unilever vs. Kimberly-Clark: Two Consumer Staples Giants, One Better Dividend
Kenvue Inc. (KVUE) PT Lifted to $19 at Barclays After Q4 Update
We recently compiled a list of the 12 Top Performing Consumer Staples Stocks in February. Kenvue Inc. (NYSE:KVUE) is one of the best performing stocks. TheFly reported on March 6 that Barclays increased its price target for KVUE to $19 from $18 while maintaining an Equal Weight rating on the stock. This revision followed updates […]
Canaccord Genuity and Barclays Raise Kenvue (KVUE) Price Targets
Kenvue Inc. (NYSE:KVUE) is one of the 10 Best Stocks Under $20 to Buy According to Hedge Funds. On March 5, Barclays increased its price target on Kenvue Inc. (NYSE:KVUE) from $18 to $19 and kept its Equalweight rating. Barclays analyst Lauren Lieberman pointed out that the company has performed relatively well in the classic […]